Clinical trial
SIMultaneous Urgent Cardiac Surgery and Endovascular Stroke Prevention Using the Micronet-covered CGUARD Stent in Hemodynamically Compromised Patients at Increased Peri-operative Stroke Risk: SIM-GUARD Study
NCT04973579 is registered in ClinicalTrials.gov with John Paul II Hospital, Krakow as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- SIMultaneous Urgent Cardiac Surgery and Endovascular Stroke Prevention Using the Micronet-covered CGUARD Stent in Hemodynamically Compromised Patients at Increased Peri-operative Stroke Risk: SIM-GUARD Study
- Lead sponsor
- John Paul II Hospital, Krakow
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 1, 2021
- Completion date
- May 1, 2027
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
carotid stenosis, coronary artery disease, myocardial infarction, pulmonary edema with heart failure, valvular heart disease